Related Experiment Videos
The clinical and economic rationale for peripheral blood progenitor cell transplantation. Introduction
1Department of Pharmacy Practice, College of Pharmacy, University of Florida Health Science Center, Gainesville 32610, USA.
Pharmacotherapy
|February 24, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects.
Clinical pharmacology and therapeutics·2006
Topotecan-filgrastim combination is an effective regimen for mobilizing peripheral blood stem cells.
Bone marrow transplantation·2001
Economic analysis of four triple regimens for the treatment of Helicobacter pylori-related peptic ulcer disease in in-patient and out-patient settings in Hong Kong.
Alimentary pharmacology & therapeutics·2001
Peripheral blood progenitor cell transplantation: economic issues.
Pharmacotherapy·1998
Cost-utility analysis of taxane therapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1998
Applied pharmacoeconomics. When can publication be legitimately withheld?
PharmacoEconomics·1997
Safety of Nonsteroidal Anti-Inflammatory Drug Use in Traumatic Brain Injury.
Pharmacotherapy·2026
Contingency Methods for Cleaning Single-Use Medical Equipment in Crisis, Disaster, or War.
Prehospital and disaster medicine·2026
Application of Human Umbilical Cord Mesenchymal Stem Cells and Their Derived Exosomes in Gastrointestinal Diseases.
International journal of nanomedicine·2026
Cost-Effectiveness of Contemporary Trigger Finger Treatment Strategies: A Medicare Payer Perspective.
Journal of hand surgery global online·2026
Clinical-Grade Cryopreservation of Human-Induced Pluripotent Stem Cells.
Methods in molecular biology (Clifton, N.J.)·2026
Predictors of high- versus low-intensity first-line multiple sclerosis treatments.
Multiple sclerosis journal - experimental, translational and clinical·2026